Kenneth I. Ataga

Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia

Martin H. Steinberg, Franca B. Barton, Oswaldo Castro et al. · JAMA · 2003 · 899 citations · Full text

Medicine, Hematology, Pharmacotherapy +9

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

Kenneth I. Ataga, Abdullah Kutlar, Julie Kanter et al. · New England Journal of Medicine · 2016 · 876 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga et al. · New England Journal of Medicine · 2019 · 609 citations · Full text

Medicine, Hematology, Hematopathology +8

The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up

Martin H. Steinberg, William F. McCarthy, Oswaldo Castro et al. · American Journal of Hematology · 2010 · 480 citations · Full text

Medicine, Hematology, Pharmacology +15

Factors associated with survival in a contemporary adult sickle cell disease cohort

Hany Elmariah, Melanie E. Garrett, Laura M. De Castro et al. · American Journal of Hematology · 2014 · 297 citations · Full text

Medicine, Hematology, Pharmacotherapy +16